Register | Login

Ere the first biologic effects to be recorded (Hisaw, 1926), and a number of studies have examined this property as a possible treatment of the connective tissue disease scleroderma. Relaxin was safe and well tolerated in clinical trials and effective in some patients in a phase II trial (Seibold et al., 2000) but failed to show clinical efficacy in a larger scale phase III trial (Erikson andUnemo

Who Voted for this Story is an open source dofollow social bookmarking site. It is managed by an optimized content management system that lets you easily submit your valuable links in order to receive search engine traffic.